-
Metformin, sold
under the
brand name Glucophage,
among others, is the main first-line
medication for the
treatment of type 2 diabetes,
particularly in...
- Sitagliptin/
metformin, sold
under the
brand name
Janumet among others, is a fixed-dose
combination anti-diabetic
medication used to
treat type 2 diabetes...
- Vildagliptin/
metformin, sold
under the
brand name
Eucreas among others, is a fixed-dose
combination anti-diabetic
medication for the
treatment of type...
- type 2
diabetes as an
adjunct to diet and exercise: as
monotherapy when
metformin is
considered inappropriate due to intolerance; in
addition to
other medicinal...
- Pioglitazone/
metformin, sold
under the
brand name
Actoplus Met
among others, is a fixed-dose
combination anti-diabetic
medication used to
improve glycemic...
- Empagliflozin/
metformin, sold
under the
brand name
Synjardy among others, is a fixed-dose
combination anti-diabetic
medication used to
treat type 2 diabetes...
-
approved in 2019,
consisting of
metformin, saxagliptin, and dapagliflozin.
Another triple combination approval for
metformin, linagliptin, and empagliflozin...
-
thiazolidinediones (glitazones), have
shown equivalent efficacy to
metformin, but
metformin has a more
favorable side
effect profile. The
United Kingdom's...
- Dapagliflozin/
metformin, sold
under the
brand name
Xigduo Xr
among others, is a fixed-dose
combination anti-diabetic
medication used as an
adjunct to...
- type 2
diabetes as an
adjunct to diet and
exercise as
monotherapy when
metformin is
considered inappropriate due to
intolerance or contraindications; in...